Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 7 SUPPL., 2009, Pages

  Malloy, Patrick C ^a   Grassi, Clement J ^b   Kundu, Sanjoy ^c   Gervais, Debra Ann ^d   Miller, Donald L ^e   Osnis, Robert B ^f   Postoak, Darren W ^g   Rajan, Dheeraj K ^h   Sacks, David ⁱ   Schwartzberg, Marc S ^j   Zuckerman, Darryl A ^k   Cardella, John F ^l  

^a HARTFORD HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SCARBOROUGH HOSPITAL   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f RADIA   (United States)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ READING HOSPITAL AND MEDICAL CENTER   (United States)

^j Radiology Associates of Central Florida   (United States)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l GEISINGER HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DESMOPRESSIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHYTOMENADIONE; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ANAPHYLAXIS; ARTICLE; BLEEDING; BLEEDING TIME; BRADYCARDIA; CENTRAL VENOUS CATHETERIZATION; CONSENSUS; CONTINUOUS INFUSION; CRYOPRECIPITATE; DEEP VEIN THROMBOSIS; HEALTH CARE QUALITY; HEART MUSCLE ISCHEMIA; HEMOPHILIA; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; INTERVENTIONAL RADIOLOGY; PARTIAL THROMBOPLASTIN TIME; PERCUTANEOUS NEPHROSTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; PULMONARY HYPERTENSION; RISK MANAGEMENT; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOSIS; VON WILLEBRAND DISEASE;

ANTICOAGULANTS; HEMOSTATIC DISORDERS; HUMANS; NORTH AMERICA; RISK MANAGEMENT; SURGERY, COMPUTER-ASSISTED; VASCULAR SURGICAL PROCEDURES;

EID: 67649823467     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.11.027     Document Type: Article

References (56)

1. Fink A., Kosefcoff J., Chassin M., and Brook R.H. Consensus methods: characteristics and guidelines for use. Am J Public Health 74 (1984) 979-998
2. Hyers T.M., Agnelli G., Hull R.D., et al. Antithrombotic therapy for venous thromboembolic disease. Chest 119 1 suppl (2001) 176S-193S
3. O'Grady J.G., Alexander G.J.M., Hayllar K.M., et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445
4. Lee W.M. Acute liver failure. N Engl J Med 329 (1993) 1862-1872
5. Pilsczek F.H., Rifkin W.D., and Walerstein S. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients. Heart Lung 34 (2005) 402-405
6. Clauss A. A rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol 17 (1957) 237-240
7. Rodgers R.P., and Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 16 (1990) 1-20
8. Hellstern P., Muntean W., Schramm W., Seifried E., and Solheim B. Practical guidelines for the clinical use of plasma. Thromb Res 107 suppl 1 (2002) S53
9. Escobar M.A. Reversal of coumarin-induced over-anticoagulation. Br J Haematol 118 (2002) 925-926 discussion 926.
10. Wilson S.E., Douketis J.D., and Crowther M.A. Treatment of warfarin-associated coagulopathy: a physician survey. Chest 120 (2001) 1972-1976
11. Jacobs L.G., and Nusbaum N. Perioperative management and reversal of antithrombotic therapy. Clin Geriatr Med 17 (2001) 189-202
12. O'Connell B.A., Lee E.J., and Schiffer C.A. The value of 10-minute post transfusion platelet counts. Transfusion 26 (1988) 66-67
13. Butterworth J., Lin Y.A., Prielipp R.C., Bennett J., Hammon J.W., and James R.L. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg 74 (2002) 1589-1595
14. Butterworth J., Lin Y.A., Prielipp R., Bennett J., and James R. The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers. Anesth Analg 94 (2002) 514-522
15. Brooks J.C. Noncardiogenic pulmonary edema immediately following rapid protamine administration. Ann Pharmacother 33 (1999) 927-930
16. Wright S.J., Murray W.B., Hampton W.A., and Hargovan H. Calculating the protamine-heparin reversal ratio: a pilot study investigating a new method. J Cardiothorac Vasc Anesth 7 (1993) 416-421
17. Lowenstein E. Lessons from studying an infrequent event: adverse hemodynamic response associated with protamine reversal of heparin anticoagulation. J Cardiothorac Anesth 3 (1989) 99-107
18. Ansell J., Hirsh J., Poller L., et al. The pharmacology and management of the vitamin K antagonists. Chest 126 suppl 3 (2004) 204S-233S
19. Raj G., Kumar R., and McKinney W.P. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med 159 (1999) 2721-2724
20. Byrd D.C., Stephens M.A., Hamann G.L., and Dorko C. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the international normalized ratio. Am J Health Syst Pharm 56 (1999) 2312-2315
21. Konkle B. Percutaneous interventions in the coagulopathic patient. Semin Intervent Radiol 22 (2005) 88-94
22. Pusateri A.E., and Park M.S. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Critical Care 9 suppl 5 (2005) S15-S24
23. Mannucci P.M., Ruggeri Z., Pareti F., and Capitanio A. 1-deamino-8-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands disease. Lancet 1 (1977) 869-872
24. Mannucci P.M., Bettega D., and Cattaneo M. Patterns of development of tachphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 82 (1992) 87-93
25. Mannucci P.M. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 72 (1988) 1449-1455
26. Dzik W., and Rao A. Why do physicians request fresh frozen plasma?. Transfusion 44 (2004) 1393
27. Stanworth S.J., Brunskill S.J., Hyde C.J., McClelland D., and Murphy M.F. Is fresh frozen plasma clinically effective?. A systematic review of randomized controlled trials. Br J Haematol 126 (2004) 1139
28. Segal J.B., and Dzik W.H. Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45 (2005) 1413-1425
29. Sawyerr A.M., McCormick P.A., Tennyson G.S., et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol 17 (1993) 81-85
30. Darcy M.D., Kanterman R.Y., Kleinhoffer M.A., et al. Evaluation of coagulation tests as predictors of angiographic bleeding complications. Radiology 198 (1996) 741-744
31. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 26 (1981) 388-393
32. Fisher N.C., and Mutimer D.J. Central venous cannulation in patients with liver disease and coagulopathy: a prospective audit. Intensive Care Med 25 (1999) 5
33. Doerfler M.E., Kaufman B., and Goldenberg A.S. Central venous catheter placement in patients with disorders of hemostasis. Chest 110 (1996) 185-188
34. Stellato T.A., Gauderer M.W., Lazarus H.M., et al. Percutaneous isoelastic catheter insertion in patients with thrombocytopenia. Cancer 56 (1985) 2691-2693
35. Morado M., Jimenez-Yuste V., Villar A., et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 7 (2001) 551-556
36. Stecker M., Johnson M., Ying J., et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol 18 (2007) 1232-1239
37. Martin J.H., Rosser C.J., Linebach R.F., McCullough D.L., and Assimos D.G. Are coagulation studies necessary before percutaneous nephrostomy?. Tech Urol 6 (2000) 205-207
38. Zagoria R.J., and Dyer R.B. Do's and don'ts of percutaneous nephrostomy. Acad Radiol 6 (1999) 370-377
39. Platelet transfusion therapy. National Institutes of Health Consensus Conference. Transfusion Med Rev 1 (1987) 195-200
40. Norfolk D.R., Ancliffe P.J., Contreras M., et al. Consensus conference on platelet transfusion. Royal College of Physicians of Edinburgh, 27-28 November 1997. Br J Haematol 101 (1998) 609-617
41. Bishop J.F., Schiffer C.A., Aisner J., et al. Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients. Am J Hematol 26 (1987) 147-155
42. Chu D.Z.J., Shivshanker K., Stroehlein J.R., et al. Thrombocytopenia and gastrointestinal hemorrhage in the cancer patient: prevalence of unmasked lesions. Gastrointest Endosc 29 (1983) 269-272
43. Weiss S.M., Hert R.C., Gianola F.J., et al. Complications of fiberoptic bronchoscopy in thrombocytopenic patients. Chest 104 (1993) 1025-1028
44. Schiffer C.A., Anderson K.C., Bennett C.L., et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1519-1538
45. McVay P.A., and Toy P.T. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 94 (1990) 747-753
46. Wallace M., Narvios A., Lichtiger B., et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol 14 (2003) 323-327
47. Ray C.E.J., and Shenoy S.S. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology 204 (1997) 97-99
48. Edelson R.N., Chernik N.L., and Posner J.B. Spinal subdural hematomas complicating lumbar puncture. Arch Neurol 31 (1974) 134-137
49. Breuer A.C., Tyler R., Marzewski D.J., et al. Radicular vessels are the most probable source of needle induced blood in lumbar puncture. Cancer 49 (1982) 2168-2172
50. Howard S.C., Gajjar A., Ribeiro R.C., et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 284 (2000) 2222-2224
51. Vavricka S.R., Walter R.B., Irani S., Halter J., and Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol 82 (2003) 570-573
52. Fox K.A., Mehta S.R., Peters R., et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial. Circulation 110 (2004) 1202-1208
53. Maier C., Gleim M., Weiss T., Stachetzki U., Nicolas V., and Zenz M. Severe bleeding following lumbar sympathetic blockade in two patients under medication with irreversible platelet aggregation inhibitors. Anesthesiology 97 (2002) 740-743
54. Hussain N., Alsulaiman R., Burtin P., et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Alimentary Pharmacol Ther 25 (2007) 579-584
55. Schafer A.I. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 35 (1995) 209-219
56. Schafer A.L. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 106 suppl 5b (1999) 25S-36S